Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) EBITDA Margin (2016 - 2025)

GeoVax Labs (GOVX) has disclosed EBITDA Margin for 15 consecutive years, with 635.81% as the latest value for Q2 2025.

  • On a quarterly basis, EBITDA Margin rose 104780.0% to 635.81% in Q2 2025 year-over-year; TTM through Sep 2025 was 761.63%, a 3100.0% increase, with the full-year FY2024 number at 635.83%, changed N/A from a year prior.
  • EBITDA Margin was 635.81% for Q2 2025 at GeoVax Labs, down from 330.22% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 209.88% in Q3 2024 to a low of 8331.46% in Q4 2021.
  • A 4-year average of 2483.22% and a median of 1550.06% in 2021 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: plummeted -780007bps in 2021, then soared 104780bps in 2025.
  • GeoVax Labs' EBITDA Margin stood at 8331.46% in 2021, then skyrocketed by 64bps to 2978.24% in 2022, then skyrocketed by 68bps to 965.32% in 2024, then surged by 34bps to 635.81% in 2025.
  • Per Business Quant, the three most recent readings for GOVX's EBITDA Margin are 635.81% (Q2 2025), 330.22% (Q1 2025), and 965.32% (Q4 2024).